Domov › Burkittov limfom › North Carolina › Durham

Klinične študije za Burkittov limfom v Durham, NC

10 študij za Burkittov limfom išče udeležence na lokacijah v Durham in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Vključevanje udeležencevFaza 2

Duke University Medical Center, Durham
UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran

366 Days – 46 Years · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Vključevanje udeležencevFaza 3

UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran

Starost 18–39 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT03150693

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Vključevanje udeležencevFaza 2

Duke University Medical Center, Durham
UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran

365 Days · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06317662

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Vključevanje udeležencevFaza 3

Duke University, Durham

Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT07648264

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Vključevanje udeležencevFaza 2

Duke University Medical Center, Durham
UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran

Starost 1–30 · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Vključevanje udeležencevFaza 3

Duke University Medical Center, Durham
UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi stran

365 Days – 25 Years · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT03959085

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Vključevanje udeležencevFaza 1/2

University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 mi stran

Starost 13–90 · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT06533579

Registry of Older Patients With Cancer

Vključevanje udeležencevOpazovalna študija

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi stran

Starost 65 in več · Vsi spoli · Posodobljeno 29. jun. 2026 · NCT01137825

Study of SGR-1505 in Mature B-Cell Neoplasms

Vključevanje udeležencevFaza 1

Duke University, Durham

Starost 18 in več · Vsi spoli · Posodobljeno 13. feb. 2026 · NCT05544019

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

Vključevanje udeležencevOpazovalna študija

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi stran

Starost 18–120 · Vsi spoli · Posodobljeno 27. okt. 2025 · NCT01137643

Študije za Burkittov limfom v drugih mestih

Druge študije v Durham

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.